Karyopharm Therap
KPTI1.9150.26% ( -0.005 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Karyopharm Therap(KPTI) predict that the Revenue is 35.07 M (+16.83%), Beat estimate;the EBIT is -26.76 M (+19.53%), Miss estimate;the EPS is -1.24 (+55.23%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.04B16.83%
0.03B4.61%
+0.00B12.22%
EBITMiss expectations
-0.03B19.53%
-0.02B30.81%
-0.00B11.28%
EPSExceed expectations
-1.2455.23%
-1.4946.21%
+0.25009.02%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf